Cure Aim Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.64 Cr
as on 16-11-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 16-11-2024
- Revenue 234.37%
(FY 2023)
- Profit 150.81%
(FY 2023)
- Ebitda -12.02%
(FY 2023)
- Net Worth 0.06%
(FY 2023)
- Total Assets 0.59%
(FY 2023)
About Cure Aim Healthcare
The Corporate was formerly known as Enzo Bio Pharma Liimited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.64 Cr.
The company currently has active open charges totaling ₹4.00 M.
Diwaker Mishra, Baljeet Talwar, Vinay Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397DL2003PTC118622
- Company No.
118622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cure Aim Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Diwaker Mishra  | Director | 01-Jun-2009 | Current |
| Baljeet Talwar | Director | 01-Jun-2009 | Current |
| Vinay Singh | Director | 01-Jun-2009 | Current |
| Aashish Oberai | Director | 11-May-2009 | Current |
Financial Performance and Corporate Structure Insights of Cure Aim Healthcare.
Cure Aim Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 234.37% increase. The company also saw a substantial improvement in profitability, with a 150.81% increase in profit. The company's net worth moved up by a moderate rise of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Aim Healthcare?
In 2023, Cure Aim Healthcare had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Expotec It Infra LlpActive 5 years 8 months
Diwaker Mishra, Vinay Singh and 1 more are mutual person
- Verdanta Harvests Private LimitedActive 15 years
Diwaker Mishra, Vinay Singh and 1 more are mutual person
- Coppice Beverages Private LimitedActive 20 years 9 months
Diwaker Mishra, Vinay Singh and 1 more are mutual person
- Lucky Global Projects Private LimitedActive 3 years 5 months
Diwaker Mishra, Vinay Singh and 1 more are mutual person
- Accord International Private LimitedActive 30 years 7 months
Diwaker Mishra, Vinay Singh and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 25 Jan 2007 | ₹4.00 M | Open |
How Many Employees Work at Cure Aim Healthcare?
Unlock and access historical data on people associated with Cure Aim Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Aim Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Aim Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
